Yaron Werber
Stock Analyst at TD Cowen
(1.50)
# 3,448
Out of 4,981 analysts
37
Total ratings
38.46%
Success rate
-5.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONC BeOne Medicines AG | Reiterates: Buy | $334 | $324.34 | +2.98% | 1 | Apr 24, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | n/a | $10.43 | - | 1 | Jan 21, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | n/a | $37.16 | - | 1 | Dec 20, 2024 | |
| SEPN Septerna | Initiates: Buy | n/a | $14.28 | - | 1 | Nov 19, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $160 → $153 | $195.58 | -21.77% | 5 | Nov 15, 2024 | |
| BNTX BioNTech SE | Maintains: Hold | $132 → $122 | $96.74 | +26.11% | 5 | Nov 6, 2024 | |
| UPB Upstream Bio | Initiates: Buy | n/a | $17.63 | - | 1 | Nov 5, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $61 → $73 | $30.31 | +140.84% | 2 | Oct 21, 2024 | |
| EXEL Exelixis | Maintains: Buy | $27 → $34 | $39.15 | -13.15% | 2 | Oct 21, 2024 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $54 → $59 | $63.16 | -6.59% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $67 | $33.11 | +102.36% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $23.46 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.43 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $8.49 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $24.44 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $612 → $641 | $756.38 | -15.25% | 3 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.93 | - | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $375 → $625 | $12.03 | +5,095.34% | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $23.96 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $27.82 | +36.59% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.08 | - | 1 | Nov 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $14.08 | - | 1 | Oct 26, 2021 |
BeOne Medicines AG
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $324.34
Upside: +2.98%
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $10.43
Upside: -
Dianthus Therapeutics
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $37.16
Upside: -
Septerna
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $14.28
Upside: -
Ascendis Pharma
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $195.58
Upside: -21.77%
BioNTech SE
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $96.74
Upside: +26.11%
Upstream Bio
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $17.63
Upside: -
Ultragenyx Pharmaceutical
Oct 21, 2024
Maintains: Buy
Price Target: $61 → $73
Current: $30.31
Upside: +140.84%
Exelixis
Oct 21, 2024
Maintains: Buy
Price Target: $27 → $34
Current: $39.15
Upside: -13.15%
Ionis Pharmaceuticals
Jul 23, 2024
Maintains: Buy
Price Target: $54 → $59
Current: $63.16
Upside: -6.59%
Jul 15, 2024
Maintains: Buy
Price Target: $71 → $67
Current: $33.11
Upside: +102.36%
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $23.46
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $2.43
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $8.49
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $24.44
Upside: -
Dec 12, 2023
Maintains: Outperform
Price Target: $612 → $641
Current: $756.38
Upside: -15.25%
Oct 19, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.93
Upside: -
Feb 28, 2023
Maintains: Market Perform
Price Target: $375 → $625
Current: $12.03
Upside: +5,095.34%
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $23.96
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $27.82
Upside: +36.59%
Nov 30, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.08
Upside: -
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $14.08
Upside: -